Copyright: ©Author(s) 2026.
World J Nephrol. Jun 25, 2026; 15(2): 117719
Published online Jun 25, 2026. doi: 10.5527/wjn.v15.i2.117719
Published online Jun 25, 2026. doi: 10.5527/wjn.v15.i2.117719
Table 6 Applications of artificial intelligence across the kidney transplantation continuum
| Phase | Clinical task | AI approach | Key performance | Clinical role | Ref. |
| Pre-transplant | Allocation and offer ranking | ML survival, ranking models | C-index 0.63-0.79 | Decision support | [77] |
| Pre-transplant | Immunologic risk | Eplet mismatch ML | Risk reclassification | Equity-aware support | [78] |
| Peri-transplant | Biopsy assessment | DL (WSI) | AUC up to 0.94 | Diagnostic support | [82] |
| Post-transplant | Tacrolimus dosing | LSTM, PK-ML | ↓ Dosing error | Dose support | [86] |
| Post-transplant | Remote monitoring | Wearables + ML | Improved adherence | Surveillance support | [90] |
- Citation: Eskandar K. Artificial intelligence in chronic kidney disease: Early detection, risk prediction, and personalized treatment strategies. World J Nephrol 2026; 15(2): 117719
- URL: https://www.wjgnet.com/2220-6124/full/v15/i2/117719.htm
- DOI: https://dx.doi.org/10.5527/wjn.v15.i2.117719